Literature DB >> 32476442

Behavioural, social and structural-level risk factors for developing AIDS among HIV-positive people who use injection drugs in a Canadian setting, 1996-2017.

S Ickowicz1, H Dong1, L Ti1,2, S Nolan1,2, N Fairbairn1,2, R Barrios3,4, M-J Milloy1,2.   

Abstract

People who use injection drugs (PWID) experience high rates of HIV acquisition and, as a result of lower rates of optimal access and adherence to combination antiretroviral therapy (ART), experience worse HIV treatment outcomes than other key affected populations. However, the incidence and risk factors for the development of AIDS among HIV-positive PWID have not been completely described. We used data from a community-recruited prospective cohort of HIV-positive PWID in Vancouver, Canada, a setting with universal no-cost ART and a comprehensive clinical monitoring registry. We used multivariable extended Cox models to identify factors associated with time to AIDS. Between 1996 and 2017, 396 participants, including 140 (35.4%) women, were followed for a median of 39.0 months (interquartile range: 16.6-76.2), among whom 165 (41.7%) developed AIDS. In a multivariable model, homelessness (Adjusted Hazard Ratio [AHR] = 1.76 (1.18-2.61)) and injection drug use within the preceding six months (AHR = 1.74 (1.17-2.58)) were independently associated with a higher risk of developing AIDS. Despite widespread scale-up of programmes to improve ART utilization, significant risk factors for the development of AIDS remain among HIV-positive PWID in this setting.

Entities:  

Keywords:  AIDS; HIV infections; antiretroviral therapy; substance abuse; treatment outcome

Mesh:

Substances:

Year:  2020        PMID: 32476442      PMCID: PMC7530072          DOI: 10.1080/09540121.2020.1772955

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  33 in total

1.  Female and male differences in AIDS diagnosis rates among people who inject drugs in large U.S. metro areas from 1993 to 2007.

Authors:  Brooke S West; Enrique R Pouget; Barbara Tempalski; Hannah L F Cooper; H Irene Hall; Xiaohong Hu; Samuel R Friedman
Journal:  Ann Epidemiol       Date:  2015-02-07       Impact factor: 3.797

Review 2.  Barriers to HIV treatment among people who use injection drugs: implications for 'treatment as prevention'.

Authors:  Michael-John Milloy; Julio Montaner; Evan Wood
Journal:  Curr Opin HIV AIDS       Date:  2012-07       Impact factor: 4.283

3.  Residential Eviction and Risk of Detectable Plasma HIV-1 RNA Viral Load Among HIV-Positive People Who Use Drugs.

Authors:  Mary Clare Kennedy; Thomas Kerr; Ryan McNeil; Surita Parashar; Julio Montaner; Evan Wood; M-J Milloy
Journal:  AIDS Behav       Date:  2017-03

4.  Social and demographical determinants of quality of life in people who live with HIV/AIDS infection: evidence from a meta-analysis.

Authors:  Hesam Ghiasvand; Peter Higgs; Mehdi Noroozi; Gholamreza Ghaedamini Harouni; Morteza Hemmat; Elahe Ahounbar; Javad Haroni; Seyran Naghdi; Ali Nazeri Astaneh; Bahram Armoon
Journal:  Biodemography Soc Biol       Date:  2019-03-18

5.  Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial.

Authors:  Beatriz Grinsztejn; Mina C Hosseinipour; Heather J Ribaudo; Susan Swindells; Joseph Eron; Ying Q Chen; Lei Wang; San-San Ou; Maija Anderson; Marybeth McCauley; Theresa Gamble; Nagalingeshwaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Jose H S Pilotto; Sheela V Godbole; Suwat Chariyalertsak; Marineide Gonçalves de Melo; Kenneth H Mayer; Susan H Eshleman; Estelle Piwowar-Manning; Joseph Makhema; Lisa A Mills; Ravindre Panchia; Ian Sanne; Joel Gallant; Irving Hoffman; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Diane Havlir; Myron S Cohen
Journal:  Lancet Infect Dis       Date:  2014-03-04       Impact factor: 25.071

6.  HIV in young people: characteristics and predictors for late diagnosis of HIV.

Authors:  N Cooney; N Hiransuthikul; S Lertmaharit
Journal:  AIDS Care       Date:  2015-02-11

Review 7.  Survival rate of AIDS disease and mortality in HIV-infected patients: a meta-analysis.

Authors:  J Poorolajal; E Hooshmand; H Mahjub; N Esmailnasab; E Jenabi
Journal:  Public Health       Date:  2016-06-24       Impact factor: 2.427

8.  Persistent racial/ethnic disparities in AIDS diagnosis rates among people who inject drugs in U.S. metropolitan areas, 1993-2007.

Authors:  Enrique R Pouget; Brooke S West; Barbara Tempalski; Hannah L F Cooper; H Irene Hall; Xiaohong Hu; Samuel R Friedman
Journal:  Public Health Rep       Date:  2014-05       Impact factor: 2.792

9.  Closing the gap: increases in life expectancy among treated HIV-positive individuals in the United States and Canada.

Authors:  Hasina Samji; Angela Cescon; Robert S Hogg; Sharada P Modur; Keri N Althoff; Kate Buchacz; Ann N Burchell; Mardge Cohen; Kelly A Gebo; M John Gill; Amy Justice; Gregory Kirk; Marina B Klein; P Todd Korthuis; Jeff Martin; Sonia Napravnik; Sean B Rourke; Timothy R Sterling; Michael J Silverberg; Stephen Deeks; Lisa P Jacobson; Ronald J Bosch; Mari M Kitahata; James J Goedert; Richard Moore; Stephen J Gange
Journal:  PLoS One       Date:  2013-12-18       Impact factor: 3.240

10.  Clinical determinants associated with quality of life for people who live with HIV/AIDS: a Meta-analysis.

Authors:  Hesam Ghiasvand; Katherine M Waye; Mehdi Noroozi; Gholamreza Ghaedamini Harouni; Bahram Armoon; Azadeh Bayani
Journal:  BMC Health Serv Res       Date:  2019-10-29       Impact factor: 2.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.